Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingjiang Ye

Showing results (71-80 of 220) with videos related to

Pageof 22
Sort By:
American Journal of Surgery|November 8, 2011
Kindlin-2: a novel adhesion protein related to tumor invasion, lymph node metastasis, and patient outcome in gastric cancerZhanlong Shen, Yingjiang Ye, Lingyi Dong, et al.
American Journal of Surgery|January 16, 2010
Metabolic syndrome is an important factor for the evolution of prognosis of colorectal cancer: survival, recurrence, and liver metastasisZhanlong Shen, Yingjiang Ye, Liang Bin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 7, 2018
The development and validation of a novel model for predicting surgical complications in colorectal cancer of elderly patients: Results from 1008 casesZhanlong Shen, Yuanpei Lin, Yingjiang Ye, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 21, 2014
Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examinedKewei Jiang, Yi Zhu, Yan Liu, et al.
International Journal of Medical Sciences|December 16, 2025
SF3A2: a promising therapeutic target and predictive biomarker for immunotherapy in colorectal cancerChangjiang Yang, Shidong Zhao, Long Zhao, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|August 19, 2003
[Stat3 signal transduction pathway orchestrates G1 to S cell cycle transition in colon cancer cells]Xiangtao Ma, Shan Wang, Ruyu Du, et al.
ANZ Journal of Surgery|June 19, 2010
Clinical study on the correlation between metabolic syndrome and colorectal carcinomaZhanlong Shen, Shan Wang, Yingjiang Ye, et al.
Journal of the American College of Surgeons|September 15, 2022
Five-Year Prognosis of Complete Mesocolic Excision in Patients with Colon Cancer: A Prospective, Nonrandomized, Double-Blind Controlled TrialChao Wang, Zhidong Gao, Zhanlong Shen, et al.
Surgical Oncology|April 13, 2021
Can transanal endoscopic microsurgery effectively treat T1 or T2 rectal cancer?A systematic review and meta-analysisXiaoyu Xiong, Chao Wang, Bo Wang, et al.
Cytokine|May 19, 2012
IL10, IL11, IL18 are differently expressed in CD14+ TAMs and play different role in regulating the invasion of gastric cancer cells under hypoxiaZhanlong Shen, Hanna Seppänen, Sanna Vainionpää, et al.
Pageof 22

Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
American Journal of Surgery|November 8, 2011
Kindlin-2: a novel adhesion protein related to tumor invasion, lymph node metastasis, and patient outcome in gastric cancerZhanlong Shen, Yingjiang Ye, Lingyi Dong, et al.
American Journal of Surgery|January 16, 2010
Metabolic syndrome is an important factor for the evolution of prognosis of colorectal cancer: survival, recurrence, and liver metastasisZhanlong Shen, Yingjiang Ye, Liang Bin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 7, 2018
The development and validation of a novel model for predicting surgical complications in colorectal cancer of elderly patients: Results from 1008 casesZhanlong Shen, Yuanpei Lin, Yingjiang Ye, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 21, 2014
Lymph node ratio as an independent prognostic indicator in stage III colorectal cancer: especially for fewer than 12 lymph nodes examinedKewei Jiang, Yi Zhu, Yan Liu, et al.
International Journal of Medical Sciences|December 16, 2025
SF3A2: a promising therapeutic target and predictive biomarker for immunotherapy in colorectal cancerChangjiang Yang, Shidong Zhao, Long Zhao, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|August 19, 2003
[Stat3 signal transduction pathway orchestrates G1 to S cell cycle transition in colon cancer cells]Xiangtao Ma, Shan Wang, Ruyu Du, et al.
ANZ Journal of Surgery|June 19, 2010
Clinical study on the correlation between metabolic syndrome and colorectal carcinomaZhanlong Shen, Shan Wang, Yingjiang Ye, et al.
Journal of the American College of Surgeons|September 15, 2022
Five-Year Prognosis of Complete Mesocolic Excision in Patients with Colon Cancer: A Prospective, Nonrandomized, Double-Blind Controlled TrialChao Wang, Zhidong Gao, Zhanlong Shen, et al.
Surgical Oncology|April 13, 2021
Can transanal endoscopic microsurgery effectively treat T1 or T2 rectal cancer?A systematic review and meta-analysisXiaoyu Xiong, Chao Wang, Bo Wang, et al.
Cytokine|May 19, 2012
IL10, IL11, IL18 are differently expressed in CD14+ TAMs and play different role in regulating the invasion of gastric cancer cells under hypoxiaZhanlong Shen, Hanna Seppänen, Sanna Vainionpää, et al.
Pageof 22